---
audienceLevel: patient
cancerTypes:
- colorectal
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: XELIRI - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/xeliri
version: v1
---

# XELIRI - NCI

# XELIRI

Placeholder slot

This chemotherapy combination contains the drugs capecitabine (Xeloda) and irinotecan hydrochloride. Combinations usually work better than single drugs because
different drugs kill
cancer
cells in different ways.

Drugs in the XELIRI combination:

|  |  |
| --- | --- |
| **XEL** | = [Capecitabine](/about-cancer/treatment/drugs/capecitabine) (Xeloda) |
| **IRI** | = [Irinotecan Hydrochloride](/about-cancer/treatment/drugs/irinotecanhydrochloride) |

Each of the drugs in this combination is approved by the
[Food and Drug
Administration (FDA)](/Common/PopUps/popDefinition.aspx?id=454785&version=Patient&language=English)
to treat cancer or conditions related to cancer.

## Use in Cancer

XELIRI
is used to treat:

- **[Colorectal cancer](/Common/PopUps/popDefinition.aspx?id=444983&version=Patient&language=English)** that has [metastasized](/Common/PopUps/popDefinition.aspx?id=46283&version=Patient&language=English) (spread to other parts of the body).
- **[Esophageal cancer](/Common/PopUps/popDefinition.aspx?id=444989&version=Patient&language=English)** that is [advanced](/Common/PopUps/popDefinition.aspx?id=478743&version=Patient&language=English) or has metastasized.
- **[Gastric (stomach) cancer](/Common/PopUps/popDefinition.aspx?id=454513&version=Patient&language=English)** that is advanced or has metastasized.

This combination may also be used with other drugs or
treatments or to treat other types of cancer.

## More About XELIRI

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/759411) - Detailed scientific definition and other names for this drug.
